Anthony M. Insogna
Partner
San Diego
Tel: 1.858.314.1130
Fax: 1.858.314.1150
Email:
aminsogna@jonesday.com
Profile
|
Experience
|
Publications
|
Speaking Engagements
Related Services
Anthony focuses his intellectual property practice on the pharmaceutical and biotechnology industries. He has extensive experience with patent issues in medicinal chemistry, peptides, antibody engineering, target-driven drug discovery, formulation development, medical devices, and other life science disciplines. He also has substantial experience with patent and trademark issues relating to health care products, medical devices, nutraceuticals (dietary and nutritional supplements), and fine and specialty chemicals.
Anthony advises start-ups, mid-cap, and multinational pharmaceutical and biotechnology companies with the strategic creation and management of patent portfolios, particularly product-driven portfolios concerning biopharmaceuticals and small molecule drug products. Anthony has significant patent litigation experience and regularly advises clients on patent enforcement issues worldwide. In addition, he has extensive experience evaluating patent portfolios and conducting due diligence for investment banking firms as well as corporations conducting mergers and acquisitions in the pharmaceutical and biotechnology areas.
Anthony has developed and implemented patent strategies for several approved pharmaceutical products and clinical candidates for companies such as Sepracor, MedImmune, BioSphere Medical, Bristol-Myers Squibb, Celgene, Esperion Therapeutics (Pfizer), and Tularik (acquired by Amgen). He has extensive experience with the Hatch-Waxman Amendments to the Food, Drug, and Cosmetic Act (e.g., ANDA cases) and the overlapping provisions of the patent laws. Anthony's experience includes patent strategies, prosecution, and enforcement issues for Allegra®, clofarabine, Embospheres®, Ethyol®, Synagis®, and Thalomid® among other approved products and products in clinical trials.
The IP Law & Business Almanac '07 listed Anthony as one of the best intellectual property law lawyers in San Diego. He was voted by his peers as a "Top Attorney" in IP litigation for 2007 by the San Diego Daily Transcript and is listed in the 2008 The Best Lawyers in America and the "Best Lawyers" issue of San Diego Magazine in the areas of biotechnology and intellectual property law. In 2008, Anthony was listed among the Daily Journal's "Leading Portfolio Managers, Patent Prosecutors and Litigators." He was also featured in the Daily Journal as one of the "Top 20 Under 40" attorneys in California for 2005, was named to the list of 2006 Southern California Super Lawyers by the publishers of Law & Politics magazine, and served as a member of the selection committee for the 2006 UCSD Chancellor's Associates Annual Faculty Excellence Awards.
Anthony worked as a law clerk in the biotechnology group of Pennie & Edmonds LLP while attending law school. He also conducted research in the chemistry departments of Columbia University and New York University. He was the recipient of an NSF undergraduate research fellowship at Columbia and an Exxon undergraduate research grant at NYU.
Admitted
New York, District of Columbia, California, U.S. Court of Appeals for the Federal Circuit, U.S. Supreme Court, U.S. District Court for the Southern District of California, and registered to practice before the U.S. Patent and Trademark Office
Education
New York University (B.S. in Organic Chemistry 1989; M.S. in Bio-organic Chemistry 1990); Fordham University (J.D. 1994)